This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
You’re reading the web version of Health Care Inc., STAT’s weekly newsletter following the flow of money in medicine. Sign up to get it in your inbox every Monday. Hello, you spry bunch. We’re coming to you on a Tuesday after yesterday’s holiday. What are you looking to read more about as the year winds down? Let us know: bob.herman@statnews.com.
On Sept. 26, the FDA approved the first truly new antipsychotic in decades: Cobenfy. In clinical trials, it didn’t cause certain side effects that traditionally interfere with medication adherence, including weight gain, lethargy, and movement disorders. I have schizoaffective disorder, bipolar type — a combination of schizophrenia and bipolar disorder — and I agree that this is a monumental development for my community.
Payroll compliance is a cornerstone of business success, yet for small and midsize businesses, it’s becoming increasingly challenging to navigate the ever-evolving landscape of federal, state, and local regulations. Mistakes can lead to costly penalties and operational disruptions, making it essential to adopt advanced solutions that ensure accuracy and efficiency.
In the early days of the Covid-19 pandemic, hospitals were desperate for ways to manage the flood of seriously ill patients. Many turned to an artificial intelligence algorithm developed by Epic Systems , the electronic health record company, to predict which patients were most likely to rapidly deteriorate so they could get the critical care they needed.
Why aren’t we doing better in the battle against cardiovascular disease? Over the last few months, STAT put that question to nearly a dozen experts in cardiology, primary care, endocrinology, and vascular disease. Nearly all of them, as a related article details, pointed to a crisis in primary care.
343
343
Signup to get articles personalized to your interests!
Pharmacist Digest brings together the best content for pharmacists from the widest variety of industry thought leaders.
Why aren’t we doing better in the battle against cardiovascular disease? Over the last few months, STAT put that question to nearly a dozen experts in cardiology, primary care, endocrinology, and vascular disease. Nearly all of them, as a related article details, pointed to a crisis in primary care.
You’re reading the web edition of STAT’s Health Tech newsletter, our guide to how technology is transforming the life sciences. Sign up to get it delivered in your inbox every Tuesday and Thursday. Why nurses liked an AI bot more than doctors did An interesting research letter out in JAMA Network Open suggests attitudes toward large language models in health care could vary based on license and professional role.
Hello everyone, my name is Diana Martinez-Nava and I am a fourth-year student pharmacist at The University of New Mexico College of Pharmacy. I would like to take some time on this special month celebrating our Hispanic Heritage to share my story on my pharmacy journey. My interest in becoming a pharmacist began around the time I was 8 years old. I was that small child who could barely see over the counter at our neighborhood pharmacy next to my father’s arm who would be reaching out to collect,
As Election Day 2024 gets closer, STAT’s First Opinion asked executives from leading biotech and pharmaceutical companies to reflect on how their industry is being portrayed in the presidential campaign — and what their hopes are for a new presidential administration. With all eyes currently on the upcoming U.S. elections, it’s easy to forget that this year more than 75 countries have headed to the polls or will soon.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Pharmacists must raise concerns with their local MPs about the issues they are facing, the Labour MP for Coventry North West and government whip Taiwo Owatemi has urged. Ms Owatemi, who is herself a pharmacist, said the profession needed to speak with a unified voice, be more vocal about concerns and collaborate with other professions. […] The post Taiwo Owatemi: 'MPs aren't hearing enough about pharmacy' appeared first on The Pharmacist.
Hello, everyone, and how are you today? We are doing just fine, thank you, especially after a lengthy weekend respite. Of course, we have returned to the usual routines, so we are firing up the trusty coffee kettle as we brace for another round of deadlines, online meetings, and the like. No doubt, you may relate. So please join us as we hoist our cup of stimulation — our choice today is cinnamon vanilla — and get cracking.
Health plans, employers, and healthcare providers plan to increase their spending on digital health technologies in the next 12 months, says PHTI survey
Hello! Hope you had a restful and reflective Indigenous Peoples’ Day. Today, we talk about how the autoimmune disease space is hotter than ever, see more gene therapy contraction, and the CEO of a generics giant talks about how elections affect industry. The need-to-know this morning Johnson & Johnson reported third-quarter earnings. Investment in autoimmune disease is soaring Investment has surged this year in autoimmune disease: More than $1.7 billion has been committed to this spac
Managing HR tasks like payroll, compliance, and employee data can overwhelm small businesses. That’s where a Human Capital Management (HCM) solution comes in. Our eBook, Why Every Small Business Needs an HCM Solution: A Comprehensive Guide , shows how an HCM system automates tedious processes, ensuring your business stays compliant and efficient. You’ll learn how to simplify payroll, eliminate costly errors, and empower your employees with self-service tools.
The big pharma company Sanofi has discontinued a phase 2 trial of U.S. partner Denali Therapeuticsâ oditrasertib for the treatment of multiple sclerosis after the drug failed to perform.
Have you ever found yourself scratching your head at the pharmacy counter, wondering why your “3-month supply” of medication doesn’t quite match up with the calendar? You’re not alone. Many people are puzzled by the discrepancy between a 92-day supply of pills and the actual number of days in a three-month period.
Social media has managed to blur the lines between work life and home life. These days many of us are growing more comfortable openly sharing things about ourselves that might not normally be public knowledge to our co-workers or our boss. With just a few clicks our pals at work can be flipping through our […] The post Creepy, Stalking Bosses appeared first on The Honest Apothecary.
Scientists have developed an efficient photocatalyst that can degrade sulfamethoxazole, a broad-spectrum antibiotic to less hazardous chemicals and reduce health and environmental concerns associated with antibiotic contamination. A team of scientists from the Institute of Advanced Study in Science and Technology (IASST), Guwahati, an autonomous institute of the Department of Science and Technology have synthesised copper zinc tin sulfide Cu2ZnSnS4 (CZTS) nanoparticles (NPs) and copper zinc tin
Payroll optimization can be one of the most time-consuming and complex factors of small business management. Yet, organizations that crack the code on streamlining employee compensation often discover innovative avenues for growth. With the right strategies in place, outsourcing and streamlining payroll processes can result in substantial time and resource savings.
Symbiosis Pharmaceutical Services, a Contract Manufacturing Organisation ( CMO) and biopharmaceutical development services provider announces the purchase of new premises in Stirling, Scotland, UK. The additional space will double the total footprint of the company across the four facilities that it will operate from, increasing manufacturing capacity by 50 per cent in the short term.
Bayer has submitted a marketing authorization application (MAA) to the European Medicines Agency (EMA) for elinzanetant for the treatment of moderate to severe vasomotor symptoms (VMS, also known as hot flashes) associated with menopause or caused by adjuvant endocrine therapy. Recent survey showed that 67% of European women reported vasomotor symptoms during menopause transition.
Lupin announced the launch of the first generic version of Pred Forte (Prednisolone Acetate) Ophthalmic Suspension USP, 1 per cent in the United States. Being the first generic to be approved and launched, the company is entitled to 180-day competitive generic therapy (CGT) exclusivity. Prednisolone Acetate Ophthalmic Suspension USP, 1 per cent is a generic equivalent of Pred Forte Ophthalmic Suspension, 1 per cent of AbbVie, and is indicated for the treatment of steroid-responsive inflammation
Running a healthcare facility requires precision and care, not just for patients but also for your staff. Our guide, "A Buyer’s Guide to Payroll & HCM Services," helps healthcare providers choose the best provider. Efficient payroll management ensures timely, accurate payments, critical for maintaining staff morale and trust. Compliance support helps navigate complex healthcare regulations and avoid costly fines.
A new survey of plan sponsors sheds light on their satisfaction with transparency at large and small pharmacy benefit managers (PBMs). As you will see, clients remain slightly more satisfied with the perceived transparency of smaller PBMs compared with the Big Three PBMs—CVS Caremark, Express Scripts, and Optum Rx. However, plan sponsors are dissatisfied with transparency about how both large and small PBMs make money.
The UK government, devolved nations and NHS England have signed a collaboration agreement with Lilly, the pharmaceutical giant behind weight loss medication tirzepatide. The government said the ‘strategic’ agreement will see Lilly investing a further £279m in the UK life sciences industry, in a bid to find new treatment models for major illnesses including obesity. […] The post Government enters ‘strategic collaboration’ with tirzepatide obesity drug maker appeared first on The Pharmacist.
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
Paul Hudson, the Briton in charge of the French drug firm, is a big believer in the potential of AI to transform healthcare Paul Hudson, the Briton who leads the French drug firm Sanofi, is “immensely” proud to have carried the torch at the recent Paralympics opening ceremony along with fellow employees, as the firm was one of the sponsors of both sets of Paris games.
Explore key forecasting considerations throughout the pharmaceutical product lifecycle, from the preclinical stage to Phase III and launch. Understand how to optimise forecasting strategies for each stage effectively.
As active pharmaceutical ingredients (APIs) and medicines become more complex and the demand for efficiency rises, drug developers and manufacturers must adapt their strategies to keep pace with the evolving landscape.
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
We organize all of the trending information in your field so you don't have to. Join 11,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content